Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Exclusion Criteria

• •1. Any concurrent illness, disability or clinically significant abnormality that may, as judged by the investigator, affect the interpretation of clinical efficacy or safety data or prevent the subject from safely completing the assessments required by the protocol.
• •2. Non-diabetic renal disease e.g. known polycystic kidney disease.
• •3. Use of LMW heparin and/or immunosuppressive drugs.
• •4. Significant food allergies for galactose, nuts, soy, tomato, corn, grape, melon and artichoke, which would make the subject unable to consume the food provided.
• •5. Signs of active infection or autoimmune disease, requiring systemic treatment.
• •6. A psychiatric, addictive or any disorder that compromises ability to give truly informed consent for participation in this study.
• •7. Malignancy (including lymphoproliferative disease) within the past 2-5 years (except for squamous or basal cell carcinoma of the skin that has been treated with no evidence of recurrence).
• •8. Use of any other investigational drug.
• •9. Patient has enrolled another clinical trial within last 4 weeks.